06/06/2026
๐๐ ๐น๐๐ป๐ด ๐ฐ๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐๐ฟ๐ฒ๐ฎ๐๐บ๐ฒ๐ป๐ ๐ฏ๐ฒ๐ฐ๐ผ๐บ๐ฒ๐ ๐ถ๐ป๐ฐ๐ฟ๐ฒ๐ฎ๐๐ถ๐ป๐ด๐น๐ ๐ฝ๐ฒ๐ฟ๐๐ผ๐ป๐ฎ๐น๐ถ๐๐ฒ๐ฑ, ๐๐ต๐ฒ ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ฎ๐ป๐ฑ ๐ฑ๐ฒ๐ฝ๐๐ต ๐ผ๐ณ ๐บ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐ถ๐ป๐๐ถ๐ด๐ต๐๐ ๐ฝ๐น๐ฎ๐ ๐ฎ ๐ฐ๐ฟ๐ถ๐๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ผ๐น๐ฒ ๐ถ๐ป ๐ด๐๐ถ๐ฑ๐ถ๐ป๐ด ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฑ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป๐.
On 21st May 2026, Oncode had the privilege of conducting a CME session with the Respiratory Department at Hospital Al-Sultan Abdullah, UiTM Puncak Alam, on the topic "Advancing Lung Cancer Care Through Molecular Testing."
The session provided an in-depth comparison of PCR and NGS technologies, highlighting their respective strengths in the molecular profiling of lung cancer for accurate diagnosis and targeted treatment selection.
We also introduced our latest upgraded NGS panels, discussing their clinical applications and how expanded genomic coverage can support more comprehensive patient management.
A key focus of the discussion was the importance of robust validation processes and quality control frameworks, ensuring the precision, sensitivity, and reliability required in molecular diagnostics.
The session concluded with engaging discussions around real-world case studies, showcasing significant findings uncovered through NGS testing and the growing role of tissue and liquid biopsy applications in modern cancer care.
Thank you to the Respiratory Department team at Hospital Al-Sultan Abdullah, UiTM Puncak Alam, for the insightful exchange and shared commitment to advancing precision oncology.
